Dietary Natural Compounds and Vitamins as Potential Cofactors in Uterine Fibroids Growth and Development
Abstract
:1. Introduction
1.1. Nutrients and Their Deficiencies
1.2. The Influence of Intestinal Dysbiosis
2. Vitamins
2.1. Carotenoids, such as Lycopene
2.2. Vitamin A. Retinoids
2.3. Vitamin E
2.4. Vitamin D
2.5. Vitamin C
2.6. Other Vitamins
3. The Active Compounds from Plants
3.1. Green Tea—Polyphenols
3.2. Curcumin/Turmeric
3.3. Quercetin and Indole-3-Carbinol
4. Micro- and Macro Elements
4.1. Selenium
4.2. Other Trace Elements
5. Endocrine-Disrupting Chemicals
6. Conclusions
7. Methods
Search Strategy
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Galindo, L.J.; Hernández-Beeftink, T.; Salas, A.; Jung, Y.; Reyes, R.; de Oca, F.M.; Hernández, M.; Almeida, T.A. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas. Gynecol. Oncol. 2018, 150, 562–568. [Google Scholar] [CrossRef] [PubMed]
- Machado-Lopez, A.; Simón, C.; Mas, A. Molecular and Cellular Insights into the Development of Uterine Fibroids. Int. J. Mol. Sci. 2021, 22, 8483. [Google Scholar] [CrossRef] [PubMed]
- Bertsch, E.; Qiang, W.; Zhang, Q.; Espona-Fiedler, M.; Druschitz, S.A.; Liu, Y.; Mittal, K.; Kong, B.; Kurita, T.; Wei, J.-J. MED12 and HMGA2 mutations: Two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod. Pathol. 2014, 27, 1144–1153. [Google Scholar] [CrossRef] [PubMed]
- Heinonen, H.-R.; Mehine, M.; Mäkinen, N.; Pasanen, A.; Pitkänen, E.; Karhu, A.; Sarvilinna, N.S.; Sjöberg, J.; Heikinheimo, O.; Bützow, R.; et al. Global metabolomic profiling of uterine leiomyomas. Br. J. Cancer 2017, 117, 1855–1864. [Google Scholar] [CrossRef] [PubMed]
- Markowski, D.N.; Bartnitzke, S.; Löning, T.; Drieschner, N.; Helmke, B.M.; Bullerdiek, J. MED12 mutations in uterine fibroids-their relationship to cytogenetic subgroups. Int. J. Cancer 2012, 131, 1528–1536. [Google Scholar] [CrossRef] [PubMed]
- Crabtree, J.S.; Jelinsky, S.A.; Harris, H.A.; Choe, S.E.; Cotreau, M.M.; Kimberland, M.L.; Wilson, E.; Saraf, K.A.; Liu, W.; McCampbell, A.S.; et al. Comparison of Human and Rat Uterine Leiomyomata: Identification of a Dysregulated Mammalian Target of Rapamycin Pathway. Cancer Res. 2009, 69, 6171–6178. [Google Scholar] [CrossRef] [Green Version]
- Fletcher, N.M.; Abusamaan, M.S.; Memaj, I.; Saed, M.G.; Al-Hendy, A.; Diamond, M.P.; Saed, G.M. Oxidative stress: A key regulator of leiomyoma cell survival. Fertil. Steril. 2017, 107, 1387–1394.e1. [Google Scholar] [CrossRef] [Green Version]
- Fletcher, N.M.; Saed, M.G.; Abu-Soud, H.M.; Al-Hendy, A.; Diamond, M.P.; Saed, G.M. Uterine fibroids are characterized by an impaired antioxidant cellular system: Potential role of hypoxia in the pathophysiology of uterine fibroids. J. Assist. Reprod. Genet. 2013, 30, 969–974. [Google Scholar] [CrossRef] [Green Version]
- Ciavattini, A.; Di Giuseppe, J.; Stortoni, P.; Montik, N.; Giannubilo, S.R.; Litta, P.; Islam, S.; Tranquilli, A.L.; Reis, F.M.; Ciarmela, P. Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction. Obstet. Gynecol. Int. 2013, 2013, 173184. [Google Scholar] [CrossRef]
- Orciani, M.; Caffarini, M.; Biagini, A.; Lucarini, G.; Carpini, G.D.; Berretta, A.; Di Primio, R.; Ciavattini, A. Chronic Inflammation May Enhance Leiomyoma Development by the Involvement of Progenitor Cells. Stem Cells Int. 2018, 2018, 1716246. [Google Scholar] [CrossRef]
- Protic, O.; Toti, P.; Islam, S.; Occhini, R.; Giannubilo, S.R.; Catherino, W.H.; Cinti, S.; Petraglia, F.; Ciavattini, A.; Castellucci, M.; et al. Possible involvement of inflammatory/reparative processes in the development of uterine fibroids. Cell Tissue Res. 2016, 364, 415–427. [Google Scholar] [CrossRef] [PubMed]
- Wise, L.A.; Wesselink, A.K.; Bethea, T.N.; Brasky, T.M.; Wegienka, G.; Harmon, Q.; Block, T.; Baird, D.D. Intake of Lycopene and other Carotenoids and Incidence of Uterine Leiomyomata: A Prospective Ultrasound Study. J. Acad. Nutr. Diet. 2021, 121, 92–104. [Google Scholar] [CrossRef] [PubMed]
- Orta, O.R.; Terry, K.L.; Missmer, S.A.; Harris, H.R. Dairy and related nutrient intake and risk of uterine leiomyoma: A prospective cohort study. Hum. Reprod. 2020, 35, 453–463. [Google Scholar] [CrossRef] [PubMed]
- He, Y.; Zeng, Q.; Dong, S.; Qin, L.; Li, G.; Wang, P. Associations between uterine fibroids and lifestyles including diet, physical activity and stress: A case-control study in China. Asia Pac. J. Clin. Nutr. 2013, 22, 109–117. [Google Scholar] [CrossRef] [PubMed]
- Shen, Y.; Wu, Y.; Lu, Q.; Ren, M. Vegetarian diet and reduced uterine fibroids risk: A case-control study in Nanjing, China. J. Obstet. Gynaecol. Res. 2016, 42, 87–94. [Google Scholar] [CrossRef]
- Wise, L.A.; Radin, R.G.; Palmer, J.R.; Kumanyika, S.K.; Boggs, D.A.; Rosenberg, L. Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata. Am. J. Clin. Nutr. 2011, 94, 1620–1631. [Google Scholar] [CrossRef] [PubMed]
- Zhou, M.; Zhai, Y.; Wang, C.; Liu, T.; Tian, S. Association of dietary diversity with uterine fibroids among urban premenopausal women in Shijiazhuang, China: A cross-sectional study. Asia Pac. J. Clin. Nutr. 2020, 29, 771–781. [Google Scholar] [CrossRef]
- Martin, C.L.; Huber, L.R.B.; Thompson, M.E.; Racine, E.F. Serum Micronutrient Concentrations and Risk of Uterine Fibroids. J. Women’s Health 2011, 20, 915–922. [Google Scholar] [CrossRef]
- Terry, K.L.; Missmer, S.A.; Hankinson, S.E.; Willett, W.C.; De Vivo, I. Lycopene and other carotenoid intake in relation to risk of uterine leiomyomata. Am. J. Obstet. Gynecol. 2008, 198, 37.e1–37.e8. [Google Scholar] [CrossRef] [Green Version]
- Wise, L.A.; Palmer, J.R.; Ruiz-Narvaez, E.; Reich, D.E.; Rosenberg, L. Is the Observed Association Between Dairy Intake and Fibroids in African Americans Explained by Genetic Ancestry? Am. J. Epidemiology 2013, 178, 1114–1119. [Google Scholar] [CrossRef] [Green Version]
- Wise, L.A.; Radin, R.; Palmer, J.; Kumanyika, S.K.; Rosenberg, L. A Prospective Study of Dairy Intake and Risk of Uterine Leiomyomata. Am. J. Epidemiology 2010, 171, 221–232. [Google Scholar] [CrossRef] [Green Version]
- Makwe, C.C.; Soibi-Harry, A.P.; Rimi, G.S.; Ugwu, O.A.; Ajayi, A.T.; Adesina, T.A.; Okunade, K.S.; Oluwole, A.A.; Anorlu, R.I. Micronutrient and Trace Element Levels in Serum of Women With Uterine Fibroids in Lagos. Cureus 2021, 13, e18638. [Google Scholar] [CrossRef] [PubMed]
- Islam, S.; Akhtar, M.M.; Segars, J.H.; Castellucci, M.; Ciarmela, P. Molecular targets of dietary phytochemicals for possible prevention and therapy of uterine fibroids: Focus on fibrosis. Crit. Rev. Food Sci. Nutr. 2017, 57, 3583–3600. [Google Scholar] [CrossRef] [PubMed]
- Gomaa, E.Z. Human gut microbiota/microbiome in health and diseases: A review. Antonie Leeuwenhoek 2020, 113, 2019–2040. [Google Scholar] [CrossRef] [PubMed]
- Szczuko, M.; Kikut, J.; Maciejewska, D.; Kulpa, D.; Celewicz, Z.; Ziętek, M. The Associations of SCFA with Anthropometric Parameters and Carbohydrate Metabolism in Pregnant Women. Int. J. Mol. Sci. 2020, 21, 9212. [Google Scholar] [CrossRef]
- Chen, D.; Jin, D.; Huang, S.; Wu, J.; Xu, M.; Liu, T.; Dong, W.; Liu, X.; Wang, S.; Zhong, W.; et al. Clostridium butyricum, a butyrate-producing probiotic, inhibits intestinal tumor development through modulating Wnt signaling and gut microbiota. Cancer Lett. 2020, 469, 456–467. [Google Scholar] [CrossRef]
- Zannotti, A.; Greco, S.; Pellegrino, P.; Giantomassi, F.; Carpini, G.D.; Goteri, G.; Ciavattini, A.; Ciarmela, P. Macrophages and Immune Responses in Uterine Fibroids. Cells 2021, 10, 982. [Google Scholar] [CrossRef]
- Chen, C.; Song, X.; Chunwei, Z.; Zhong, H.; Dai, J.; Lan, Z.; Li, F.; Yu, X.; Feng, Q.; Wang, Z.; et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat. Commun. 2017, 8, 875. [Google Scholar] [CrossRef] [Green Version]
- Torun, A.; Hupalowska, A.; Trzonkowski, P.; Kierkus, J.; Pyrzynska, B. Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children. Front. Immunol. 2021, 12, 642166. [Google Scholar] [CrossRef]
- De Luca, F.; Shoenfeld, Y. The microbiome in autoimmune diseases. Clin. Exp. Immunol. 2019, 195, 74–85. [Google Scholar] [CrossRef] [Green Version]
- Wieërs, G.; Belkhir, L.; Enaud, R.; Leclercq, S.; De Foy, J.-M.P.; Dequenne, I.; De Timary, P.; Cani, P.D. How Probiotics Affect the Microbiota. Front. Cell. Infect. Microbiol. 2020, 9, 454. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Eslami, M.; Bahar, A.; Keikha, M.; Karbalaei, M.; Kobyliak, N.; Yousefi, B. Probiotics function and modulation of the immune system in allergic diseases. Allergol. Immunopathol. 2020, 48, 771–788. [Google Scholar] [CrossRef] [PubMed]
- Ballini, A.; Santacroce, L.; Cantore, S.; Bottalico, L.; Dipalma, G.; Topi, S.; Saini, R.; De Vito, D.; Inchingolo, F. Probiotics Efficacy on Oxidative Stress Values in Inflammatory Bowel Disease: A Randomized Double-Blinded Placebo-Controlled Pilot Study. Endocrine, Metab. Immune Disord. Drug Targets 2019, 19, 373–381. [Google Scholar] [CrossRef] [PubMed]
- Rezazadeh, L.; Alipour, B.; Jafarabadi, M.A.; Behrooz, M.; Gargari, B.P. Daily consumption effects of probiotic yogurt containing Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 on oxidative stress in metabolic syndrome patients. Clin. Nutr. ESPEN 2021, 41, 136–142. [Google Scholar] [CrossRef] [PubMed]
- Sahin, K.; Ozercan, R.; Onderci, M.; Sahin, N.; Gursu, M.F.; Khachik, F.; Sarkar, F.H.; Munkarah, A.; Ali-Fehmi, R.; Kmak, D.; et al. Lycopene Supplementation Prevents the Development of Spontaneous Smooth Muscle Tumors of the Oviduct in Japanese Quail. Nutr. Cancer 2004, 50, 181–189. [Google Scholar] [CrossRef]
- Sahin, K.; Ozercan, R.; Onderci, M.; Sahin, N.; Khachik, F.; Seren, S.; Kucuk, O. Dietary Tomato Powder Supplementation in the Prevention of Leiomyoma of the Oviduct in the Japanese Quail. Nutr. Cancer 2007, 59, 70–75. [Google Scholar] [CrossRef] [PubMed]
- Broaddus, R.R.; Xie, S.; Hsu, C.-J.; Wang, J.; Zhang, S.; Zou, C. The chemopreventive agents 4-HPR and DFMO inhibit growth and induce apoptosis in uterine leiomyomas. Am. J. Obstet. Gynecol. 2004, 190, 686–692. [Google Scholar] [CrossRef] [PubMed]
- Zaitseva, M.; Vollenhoven, B.J.; Rogers, P.A. Retinoids regulate genes involved in retinoic acid synthesis and transport in human myometrial and fibroid smooth muscle cells. Hum. Reprod. 2008, 23, 1076–1086. [Google Scholar] [CrossRef]
- Lattuada, D.; Vigano, P.; Mangioni, S.; Sassone, J.; Di Francesco, S.; Vignali, M.; Di Blasio, A.M. Accumulation of Retinoid X Receptor-
α in Uterine Leiomyomas Is Associated with a Delayed Ligand-Dependent Proteasome-Mediated Degradation and an Alteration of Its Transcriptional Activity. Mol. Endocrinol. 2007, 21, 602–612. [Google Scholar] [CrossRef] [Green Version] - Ben-Sasson, H.; Ben-Meir, A.; Shushan, A.; Karra, L.; Rojansky, N.; Klein, B.Y.; Levitzki, R.; Ben-Bassat, H. All-trans-retinoic acid mediates changes in PI3K and retinoic acid signaling proteins of leiomyomas. Fertil. Steril. 2011, 95, 2080–2086. [Google Scholar] [CrossRef]
- Malik, M.; Webb, J.; Catherino, W.H. Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells. Clin. Endocrinol. 2008, 69, 462–470. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Czeczuga-Semeniuk, E.; Wołczyński, S. Dietary carotenoids in normal and pathological tissues of corpus uteri. Folia Histochem. Cytobiol. 2008, 46, 283–290. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zaitseva, M.; Vollenhoven, B.J.; Rogers, P.A.W. Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium. Mol. Hum. Reprod. 2007, 13, 577–585. [Google Scholar] [CrossRef]
- Catherino, W.H.; Malik, M. Uterine leiomyomas express a molecular pattern that lowers retinoic acid exposure. Fertil. Steril. 2007, 87, 1388–1398. [Google Scholar] [CrossRef] [PubMed]
- Zaitseva, M.; Holdsworth-Carson, S.J.; Waldrip, L.; Nevzorova, J.; Martelotto, L.; Vollenhoven, B.J.; Rogers, P.A.W. Aberrant expression and regulation of NR2F2 and CTNNB1 in uterine fibroids. Reproduction 2013, 146, 91–102. [Google Scholar] [CrossRef] [PubMed]
- Traber, M.G.; Stevens, J.F. Vitamins C and E: Beneficial effects from a mechanistic perspective. Free Radic. Biol. Med. 2011, 51, 1000–1013. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ciebiera, M.; Szymańska-Majchrzak, J.; Sentkowska, A.; Kilian, K.; Rogulski, Z.; Nowicka, G.; Jakiel, G.; Tomaszewski, P.; Włodarczyk, M. Alpha-Tocopherol Serum Levels Are Increased in Caucasian Women with Uterine Fibroids: A Pilot Study. BioMed Res. Int. 2018, 2018, 6793726. [Google Scholar] [CrossRef] [Green Version]
- Halder, S.K.; Osteen, K.G.; Al-Hendy, A. 1,25-Dihydroxyvitamin D3 Reduces Extracellular Matrix-Associated Protein Expression in Human Uterine Fibroid Cells. Biol. Reprod. 2013, 89, 150. [Google Scholar] [CrossRef]
- Lima, M.S.O.; da Silva, B.B.; de Medeiros, M.L.; dos Santos, A.R.; Brazil, E.D.D.N.; Filho, W.M.N.E.; Ibiapina, J.O.; Brito, A.G.A.; Costa, P.V.L. Evaluation of vitamin D receptor expression in uterine leiomyoma and nonneoplastic myometrial tissue: A cross-sectional controlled study. Reprod. Biol. Endocrinol. 2021, 19, 67. [Google Scholar] [CrossRef]
- Al-Hendy, A.; Diamond, M.P.; El-Sohemy, A.; Halder, S.K. 1,25-dihydroxyvitamin D3 regulates expression of sex steroid receptors in human uterine fibroid cells. J. Clin. Endocrinol. Metab. 2015, 100, E572–E582. [Google Scholar] [CrossRef] [Green Version]
- Kennel, K.A.; Drake, M.T.; Hurley, D.L. Vitamin D Deficiency in Adults: When to Test and How to Treat. Mayo Clin. Proc. 2010, 85, 752–758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Al-Hendy, A.; Halder, S.K.; Allah, A.S.A.; Roshdy, E.; Rajaratnam, V.; Sabry, M. Serum vitamin D3 level inversely correlates with uterine fibroid volume in different ethnic groups: A cross-sectional observational study. Int. J. Women’s Health 2013, 5, 93–100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Baird, D.D.; Hill, M.C.; Schectman, J.M.; Hollis, B.W. Vitamin D and the Risk of Uterine Fibroids. Epidemiology 2013, 24, 447–453. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Paffoni, A.; Somigliana, E.; Vigano, P.; Benaglia, L.; Cardellicchio, L.; Pagliardini, L.; Papaleo, E.; Candiani, M.; Fedele, L. Vitamin D Status in Women With Uterine Leiomyomas. J. Clin. Endocrinol. Metab. 2013, 98, E1374–E1378. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, S.; Chen, B.; Sheng, B.; Wang, J.; Zhu, X. The associations between serum vitamin D, calcium and uterine fibroids in Chinese women: A case-controlled study. J. Int. Med Res. 2020, 48, 300060520923492. [Google Scholar] [CrossRef]
- Brakta, S.; Diamond, J.S.; Al-Hendy, A.; Diamond, M.; Halder, S.K. Role of vitamin D in uterine fibroid biology. Fertil. Steril. 2015, 104, 698–706. [Google Scholar] [CrossRef] [Green Version]
- Wise, L.A.; Ruiz-Narváez, E.A.; Haddad, S.A.; Rosenberg, L.; Palmer, J.R. Polymorphisms in vitamin D–related genes and risk of uterine leiomyomata. Fertil. Steril. 2014, 102, 503–510.e1. [Google Scholar] [CrossRef] [Green Version]
- Singh, V.; Barik, A.; Imam, N. Vitamin D3 Level in Women with Uterine Fibroid: An Observational Study in Eastern Indian Population. J. Obstet. Gynecol. India 2019, 69, 161–165. [Google Scholar] [CrossRef]
- Tunau, K.A.; Garba, J.A.; Panti, A.A.; Shehu, C.E.; Adamu, A.N.; AbdulRahman, M.B.; Ahmad, M.K. Low plasma vitamin D as a predictor of uterine fibroids in a nigerian population. Niger. Postgrad. Med J. 2021, 28, 181–186. [Google Scholar] [CrossRef]
- Xu, F.; Li, F.; Li, L.; Lin, D.; Hu, H.; Shi, Q. Vitamin D as a risk factor for the presence of asymptomatic uterine fibroids in premenopausal Han Chinese women. Fertil. Steril. 2021, 115, 1288–1293. [Google Scholar] [CrossRef]
- Bläuer, M.; Rovio, P.H.; Ylikomi, T.; Heinonen, P.K. Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro. Fertil. Steril. 2009, 91, 1919–1925. [Google Scholar] [CrossRef] [PubMed]
- ElHusseini, H.; Elkafas, H.; Abdelaziz, M.; Halder, S.; Atabiekov, I.; Eziba, N.; Ismail, N.; El Andaloussi, A.; Al-Hendy, A. Diet-induced vitamin D deficiency triggers inflammation and DNA damage profile in murine myometrium. Int. J. Women’s Health 2018, 10, 503–514. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Othman, E.R.; Ahmed, E.; Sayed, A.A.; Hussein, M.; Abdelaal, I.I.; Fetih, A.N.; Abou-Taleb, H.A.; Yousef, A.-E.A. Human uterine leiomyoma contains low levels of 1, 25 dihdroxyvitamin D3, and shows dysregulated expression of vitamin D metabolizing enzymes. Eur. J. Obstet. Gynecol. Reprod. Biol. 2018, 229, 117–122. [Google Scholar] [CrossRef] [PubMed]
- Ciebiera, M.; Włodarczyk, M.; Słabuszewska-Jóźwiak, A.; Nowicka, G.; Jakiel, G. Influence of vitamin D and transforming growth factor
β 3 serum concentrations, obesity, and family history on the risk for uterine fibroids. Fertil. Steril. 2016, 106, 1787–1792. [Google Scholar] [CrossRef] [Green Version] - Islam, S.; Ciavattini, A.; Petraglia, F.; Castellucci, M.; Ciarmela, P. Extracellular matrix in uterine leiomyoma pathogenesis: A potential target for future therapeutics. Hum. Reprod. Updat. 2018, 24, 59–85. [Google Scholar] [CrossRef] [Green Version]
- Arici, A.; Sozen, I. Transforming growth factor-
β 3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil. Steril. 2000, 73, 1006–1011. [Google Scholar] [CrossRef] - Ciavattini, A.; Carpini, G.D.; Serri, M.; Vignini, A.; Sabbatinelli, J.; Tozzi, A.; Aggiusti, A.; Clemente, N. Hypovitaminosis D and “small burden” uterine fibroids: Opportunity for a vitamin D supplementation. Medicine 2016, 95, e5698. [Google Scholar] [CrossRef]
- Kaplan, Z.A.O.; Taşçi, Y.; Topçu, H.O.; Erkaya, S. 25-Hydroxy vitamin D levels in premenopausal Turkish women with uterine leiomyoma. Gynecol. Endocrinol. 2018, 34, 261–264. [Google Scholar] [CrossRef]
- Halder, S.K.; Sharan, C.; Al-Hendy, O.; Al-Hendy, A. Paricalcitol, a Vitamin D Receptor Activator, Inhibits Tumor Formation in a Murine Model of Uterine Fibroids. Reprod. Sci. 2014, 21, 1108–1119. [Google Scholar] [CrossRef] [Green Version]
- Halder, S.K.; Sharan, C.; Al-Hendy, A. 1,25-Dihydroxyvitamin D3 Treatment Shrinks Uterine Leiomyoma Tumors in the Eker Rat Model1. Biol. Reprod. 2012, 86, 116. [Google Scholar] [CrossRef]
- Corachán, A.; Ferrero, H.; Aguilar, A.; Garcia, N.; Monleon, J.; Faus, A.; Cervelló, I.; Pellicer, A. Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/
β -catenin pathway. Fertil. Steril. 2019, 111, 397–407. [Google Scholar] [CrossRef] [PubMed] [Green Version] - Khan, K.N.; Fujishita, A.; Koshiba, A.; Ogawa, K.; Mori, T.; Ogi, H.; Itoh, K.; Teramukai, S.; Kitawaki, J. Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas. PLoS ONE 2020, 15, e0242246. [Google Scholar] [CrossRef] [PubMed]
- Szydłowska, I.; Grabowska, M.; Nawrocka-Rutkowska, J.; Piasecka, M.; Starczewski, A. Markers of Cellular Proliferation, Apoptosis, Estrogen/Progesterone Receptor Expression and Fibrosis in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids. J. Clin. Med. 2021, 10, 562. [Google Scholar] [CrossRef]
- Sharan, C.; Halder, S.K.; Thota, C.; Jaleel, T.; Nair, S.; Al-Hendy, A. Vitamin D inhibits proliferation of human uterine leiomyoma cells via catechol-O-methyltransferase. Fertil. Steril. 2011, 95, 247–253. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Halder, S.K.; Goodwin, J.S.; Al-Hendy, A. 1,25-Dihydroxyvitamin D3 Reduces TGF-
β 3-Induced Fibrosis-Related Gene Expression in Human Uterine Leiomyoma Cells. J. Clin. Endocrinol. Metab. 2011, 96, E754–E762. [Google Scholar] [CrossRef] - Hajhashemi, M.; Ansari, M.; Haghollahi, F.; Eslami, B. The effect of vitamin D supplementation on the size of uterine leiomyoma in women with vitamin D deficiency. Casp. J. Intern. Med. 2019, 10, 125–131. [Google Scholar] [CrossRef]
- Arjeh, S.; Darsareh, F.; Asl, Z.A.; Kutenaei, M.A. Effect of oral consumption of vitamin D on uterine fibroids: A randomized clinical trial. Complement. Ther. Clin. Pr. 2020, 39, 101159. [Google Scholar] [CrossRef]
- Tanha, F.D.; Feizabad, E.; Farahani, M.V.; Amuzegar, H.; Moradi, B.; Sadeh, S.S. The Effect of Vitamin D Deficiency on Overgrowth of Uterine Fibroids: A Blinded Randomized Clinical Tria. Int. J. Fertil. Steril. 2021, 15, 95–100. [Google Scholar] [CrossRef]
- Suneja, A.; Faridi, F.; Bhatt, S.; Guleria, K.; Mehndiratta, M.; Sharma, R. Effect of Vitamin D3 supplementation on symptomatic uterine leiomyoma in women with Hypovitaminosis D. J. Midlife Health 2021, 12, 53–60. [Google Scholar] [CrossRef]
- Corachán, A.; Ferrero, H.; Escrig, J.; Monleon, J.; Faus, A.; Cervelló, I.; Pellicer, A. Long-term vitamin D treatment decreases human uterine leiomyoma size in a xenograft animal model. Fertil. Steril. 2020, 113, 205–216.e4. [Google Scholar] [CrossRef]
- Halder, S.K.; Osteen, K.G.; Al-Hendy, A. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells. Hum. Reprod. 2013, 28, 2407–2416. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Al-Hendy, A.; Diamond, M.P.; Boyer, T.G.; Halder, S.K. Vitamin D3 Inhibits Wnt/
β -Catenin and mTOR Signaling Pathways in Human Uterine Fibroid Cells. J. Clin. Endocrinol. Metab. 2016, 101, 1542–1551. [Google Scholar] [CrossRef] [PubMed] [Green Version] - Corachán, A.; Trejo, M.G.; Carbajo-García, M.C.; Monleón, J.; Escrig, J.; Faus, A.; Pellicer, A.; Cervelló, I.; Ferrero, H. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation. Fertil. Steril. 2021, 115, 512–521. [Google Scholar] [CrossRef] [PubMed]
- Ali, M.; Shahin, S.M.; Sabri, N.A.; Al-Hendy, A.; Yang, Q. Hypovitaminosis D exacerbates the DNA damage load in human uterine fibroids, which is ameliorated by vitamin D3 treatment. Acta Pharmacol. Sin. 2019, 40, 957–970. [Google Scholar] [CrossRef]
- Elkafas, H.; Ali, M.; Elmorsy, E.; Kamel, R.; Thompson, W.E.; Badary, O.; Al-Hendy, A.; Yang, Q.; Yang, Q. Vitamin D3 Ameliorates DNA Damage Caused by Developmental Exposure to Endocrine Disruptors in the Uterine Myometrial Stem Cells of Eker Rats. Cells 2020, 9, 1459. [Google Scholar] [CrossRef]
- Xess, S.; Sahu, J. A study to correlate association between vitamin D with fibroid and its supplementation in the progression of the disease. Int. J. Reprod. Contracept. Obstet. Gynecol. 2020, 9, 1477–1481. [Google Scholar] [CrossRef] [Green Version]
- Sheng, B.; Song, Y.; Liu, Y.; Jiang, C.; Zhu, X. Association between vitamin D and uterine fibroids: A study protocol of an open-label, randomised controlled trial. BMJ Open 2020, 10, e038709. [Google Scholar] [CrossRef]
- Porcaro, G.; Santamaria, A.; Giordano, D.; Angelozzi, P. Vitamin D plus epigallocatechin gallate: A novel promising approach for uterine myomas. Eur. Rev. Med. Pharmacol. Sci. 2020, 24, 3344–3351. [Google Scholar]
- Yılmaz, S.G.; Gul, T.; Attar, R.; Yıldırım, G.; Isbir, T. Association between fok1 polymorphism of vitamin D receptor gene with uterine leiomyoma in Turkish populations. J. Turk. Ger. Gynecol. Assoc. 2018, 19, 128–131. [Google Scholar] [CrossRef]
- Fazeli, E.; Piltan, S.; Gholami, M.; Akbari, M.; Falahati, Z.; Yassaee, F.; Sadeghi, H.; Mirfakhraie, R. CYP24A1 expression analysis in uterine leiomyoma regarding MED12 mutation profile. Arch. Gynecol. Obstet. 2021, 303, 787–792. [Google Scholar] [CrossRef]
- Man, A.M.S.-D.; Elbers, P.; Straaten, H.M.O.-V. Vitamin C: Should we supplement? Curr. Opin. Crit. Care 2018, 24, 248–255. [Google Scholar] [CrossRef]
- Lee, B.; Kim, K.; Cho, H.Y.; Yang, E.J.; Suh, D.H.; No, J.H.; Lee, J.R.; Hwang, J.W.; Do, S.H.; Kim, Y.B. Effect of intravenous ascorbic acid infusion on blood loss during laparoscopic myomectomy: A randomized, double-blind, placebo-controlled trial. Eur. J. Obstet. Gynecol. Reprod. Biol. 2016, 199, 187–191. [Google Scholar] [CrossRef] [PubMed]
- Pourmatroud, E.; Hormozi, L.; Hemadi, M.; Golshahi, R. Intravenous ascorbic acid (vitamin C) administration in myomectomy: A prospective, randomized, clinical trial. Arch. Gynecol. Obstet. 2012, 285, 111–115. [Google Scholar] [CrossRef]
- Zhang, D.; Al-Hendy, M.; Richard-Davis, G.; Montgomery-Rice, V.; Rajaratnam, V.; Al-Hendy, A. Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil. Steril. 2010, 94, 1887–1893. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhang, N.; Rajaratnam, V.; Al-Hendy, O.; Halder, S.; Al-Hendy, A. Green Tea Extract Inhibition of Human Leiomyoma Cell Proliferation Is Mediated via Catechol- O -Methyltransferase. Gynecol. Obstet. Investig. 2014, 78, 109–118. [Google Scholar] [CrossRef]
- Zhang, D.; Al-Hendy, M.; Richard-Davis, G.; Montgomery-Rice, V.; Sharan, C.; Rajaratnam, V.; Khurana, A.; Al-Hendy, A. Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice. Am. J. Obstet. Gynecol. 2010, 202, 289.e1–289.e9. [Google Scholar] [CrossRef] [Green Version]
- Ozercan, I.H.; Sahin, N.; Akdemir, F.; Onderci, M.; Seren, S.; Sahin, K.; Kucuk, O. Chemoprevention of fibroid tumors by [−]-epigallocatechin-3-gallate in quail. Nutr. Res. 2008, 28, 92–97. [Google Scholar] [CrossRef]
- Al-Hendy, A.; Roshdy, E.; Rajaratnam, V.; Maitra, S.; Sabry, M.; Allah, A.S.A. Treatment of symptomatic uterine fibroids with green tea extract: A pilot randomized controlled clinical study. Int. J. Women’s Health 2013, 5, 477–486. [Google Scholar] [CrossRef] [Green Version]
- EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS); Younes, M.; Aggett, P.; Aguilar, F.; Crebelli, R.; Dusemund, B.; Filipič, M.; Frutos, M.J.; Galtier, P.; Gott, D.; et al. Scientific opinion on the safety of green tea catechins. EFSA J. 2018, 16, e05239. [Google Scholar] [CrossRef] [Green Version]
- Grandi, G.; Del Savio, M.C.; Melotti, C.; Feliciello, L.; Facchinetti, F. Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: A pilot, prospective, daily-diary based study. Gynecol. Endocrinol. 2021, 38, 63–67. [Google Scholar] [CrossRef]
- Miriello, D.; Galanti, F.; Cignini, P.; Antonaci, D.; Schiavi, M.C.; Rago, R. Uterine fibroids treatment: Do we have new valid alternative? Experiencing the combination of vitamin D plus epigallocatechin gallate in childbearing age affected women. Eur. Rev. Med. Pharmacol. Sci. 2021, 25, 2843–2851. [Google Scholar] [CrossRef]
- Ahmed, R.S.I.; Liu, G.; Renzetti, A.; Farshi, P.; Yang, H.; Soave, C.; Saed, G.; El-Ghoneimy, A.A.; El Banna, H.; Foldes, R.; et al. Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines. J. Cell. Biochem. 2016, 117, 2357–2369. [Google Scholar] [CrossRef]
- Biro, R.; Richter, R.; Ortiz, M.; Sehouli, J.; David, M. Effects of epigallocatechin gallate-enriched green tea extract capsules in uterine myomas: Results of an observational study. Arch. Gynecol. Obstet. 2021, 303, 1235–1243. [Google Scholar] [CrossRef] [PubMed]
- Hewlings, S.J.; Kalman, D.S. Curcumin: A Review of Its Effects on Human Health. Foods 2017, 6, 92. [Google Scholar] [CrossRef] [PubMed]
- Xu, X.-Y.; Meng, X.; Li, S.; Gan, R.-Y.; Li, Y.; Li, H.-B. Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives. Nutrients 2018, 10, 1553. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- McCubrey, J.A.; Lertpiriyapong, K.; Steelman, L.S.; Abrams, S.L.; Yang, L.V.; Murata, R.M.; Rosalen, P.L.; Scalisi, A.; Neri, L.M.; Cocco, L.; et al. Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging 2017, 9, 1477–1536. [Google Scholar] [CrossRef] [Green Version]
- Malik, M.; Mendoza, M.; Payson, M.; Catherino, W.H. Curcumin, a nutritional supplement with antineoplastic activity, enhances leiomyoma cell apoptosis and decreases fibronectin expression. Fertil. Steril. 2009, 91, 2177–2184. [Google Scholar] [CrossRef]
- Tsuiji, K.; Takeda, T.; Li, B.; Wakabayashi, A.; Kondo, A.; Kimura, T.; Yaegashi, N. Inhibitory effect of curcumin on uterine leiomyoma cell proliferation. Gynecol. Endocrinol. 2011, 27, 512–517. [Google Scholar] [CrossRef]
- Feng, Y.; Zhao, Y.; Li, Y.; Peng, T.; Kuang, Y.; Shi, X.; Wang, G.; Peng, F.; Yu, C. Inhibition of Fibroblast Activation in Uterine Leiomyoma by Components of Rhizoma Curcumae and Rhizoma Sparganii. Front. Public Health 2021, 9, 650022. [Google Scholar] [CrossRef]
- Yu, C.H.; Zhao, J.S.; Zhao, H.; Peng, T.; Shen, D.C.; Xu, Q.X.; Li, Y.; Webb, R.C.; Wang, M.H.; Shi, X.M.; et al. Transcriptional profiling of uterine leiomyoma rats treated by a traditional herb pair, Curcumae rhizoma and Sparganii rhizoma. Braz. J. Med Biol. Res. 2019, 52, e8132. [Google Scholar] [CrossRef] [Green Version]
- Greco, S.; Islam, S.; Zannotti, A.; Carpini, G.D.; Giannubilo, S.R.; Ciavattini, A.; Petraglia, F.; Ciarmela, P. Quercetin and indole-3-carbinol inhibit extracellular matrix expression in human primary uterine leiomyoma cells. Reprod. Biomed. Online 2020, 40, 593–602. [Google Scholar] [CrossRef] [PubMed]
- Zhang, P.; Zhang, C.; Wang, X.; Liu, F.; Sung, C.J.; Quddus, M.R.; Lawrence, W.D. The expression of selenium-binding protein 1 is decreased in uterine leiomyoma. Diagn. Pathol. 2010, 5, 80. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tuzcu, M.; Sahin, N.; Özercan, I.; Seren, S.; Sahin, K.; Kucuk, O. The Effects of Selenium Supplementation on the Spontaneously Occurring Fibroid Tumors of Oviduct, 8-Hydroxy-2′-Deoxyguanosine Levels, and Heat Shock Protein 70 Response in Japanese Quail. Nutr. Cancer 2010, 62, 495–500. [Google Scholar] [CrossRef] [PubMed]
- Nasiadek, M.; Krawczyk, T.; Sapota, A. Tissue levels of cadmium and trace elements in patients with myoma and uterine cancer. Hum. Exp. Toxicol. 2005, 24, 623–630. [Google Scholar] [CrossRef]
- Johnstone, E.B.; Louis, G.M.B.; Parsons, P.J.; Steuerwald, A.J.; Palmer, C.D.; Chen, Z.; Sun, L.; Hammoud, A.O.; Dorais, J.; Peterson, C.M. Increased urinary cobalt and whole blood concentrations of cadmium and lead in women with uterine leiomyomata: Findings from the ENDO Study. Reprod. Toxicol. 2014, 49, 27–32. [Google Scholar] [CrossRef] [Green Version]
- Elkafas, H.; Badary, O.A.; Elmorsy, E.; Kamel, R.; Yang, Q.; Al-Hendy, A. Endocrine-Disrupting Chemicals and Vitamin D Deficiency in the Pathogenesis of Uterine Fibroids. J. Adv. Pharm. Res. 2021, 5, 248–263. [Google Scholar] [CrossRef]
- Chiang, Y.-F.; Chen, H.-Y.; Ali, M.; Shieh, T.-M.; Huang, Y.-J.; Wang, K.-L.; Chang, H.-Y.; Huang, T.-C.; Hong, Y.-H.; Hsia, S.-M. The Role of Cell Proliferation and Extracellular Matrix Accumulation Induced by Food Additive Butylated Hydroxytoluene in Uterine Leiomyoma. Nutrients 2021, 13, 3074. [Google Scholar] [CrossRef]
- Wang, K.-H.; Kao, A.-P.; Chang, C.-C.; Lin, T.-C.; Kuo, T.-C. Bisphenol A at environmentally relevant doses induces cyclooxygenase-2 expression and promotes invasion of human mesenchymal stem cells derived from uterine myoma tissue. Taiwan. J. Obstet. Gynecol. 2013, 52, 246–252. [Google Scholar] [CrossRef] [Green Version]
- Neblett, M.F., 2nd; Curtis, S.W.; Gerkowicz, S.A.; Spencer, J.B.; Terrell, M.L.; Jiang, V.S.; Marder, M.E.; Barr, D.B.; Marcus, M.; Smith, A.K. Examining Reproductive Health Outcomes in Females Exposed to Polychlorinated Biphenyl and Polybrominated Biphenyl. Sci. Rep. 2020, 10, 3314–3319. [Google Scholar] [CrossRef]
- Wesselink, A.K.; Henn, B.C.; Fruh, V.; Orta, O.R.; Weuve, J.; Hauser, R.; Williams, P.L.; McClean, M.D.; Sjodin, A.; Bethea, T.N.; et al. A Prospective Ultrasound Study of Plasma Polychlorinated Biphenyl Concentrations and Incidence of Uterine Leiomyomata. Epidemiology 2021, 32, 259–267. [Google Scholar] [CrossRef]
- Ali, M.; Shahin, S.M.; Sabri, N.A.; Al-Hendy, A.; Yang, Q. 1,25 Dihydroxyvitamin D3 Enhances the Antifibroid Effects of Ulipristal Acetate in Human Uterine Fibroids. Reprod. Sci. 2019, 26, 812–828. [Google Scholar] [CrossRef] [PubMed]
- Ciebiera, M.; Męczekalski, B.; Lukaszuk, K.; Jakiel, G. Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy—2 case studies. Gynecol. Endocrinol. 2019, 35, 473–477. [Google Scholar] [CrossRef] [PubMed]
- Afrin, S.; AlAshqar, A.; El Sabeh, M.; Miyashita-Ishiwata, M.; Reschke, L.; Brennan, J.T.; Fader, A.; Borahay, M.A. Diet and Nutrition in Gynecological Disorders: A Focus on Clinical Studies. Nutrients 2021, 13, 1747. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Szydłowska, I.; Nawrocka-Rutkowska, J.; Brodowska, A.; Marciniak, A.; Starczewski, A.; Szczuko, M. Dietary Natural Compounds and Vitamins as Potential Cofactors in Uterine Fibroids Growth and Development. Nutrients 2022, 14, 734. https://doi.org/10.3390/nu14040734
Szydłowska I, Nawrocka-Rutkowska J, Brodowska A, Marciniak A, Starczewski A, Szczuko M. Dietary Natural Compounds and Vitamins as Potential Cofactors in Uterine Fibroids Growth and Development. Nutrients. 2022; 14(4):734. https://doi.org/10.3390/nu14040734
Chicago/Turabian StyleSzydłowska, Iwona, Jolanta Nawrocka-Rutkowska, Agnieszka Brodowska, Aleksandra Marciniak, Andrzej Starczewski, and Małgorzata Szczuko. 2022. "Dietary Natural Compounds and Vitamins as Potential Cofactors in Uterine Fibroids Growth and Development" Nutrients 14, no. 4: 734. https://doi.org/10.3390/nu14040734